CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

被引:224
|
作者
Skillback, Tobias [1 ]
Farahmand, Bahman [2 ,3 ,4 ]
Bartlett, Jonathan W. [5 ]
Rosen, Christoffer [1 ]
Mattsson, Niklas [1 ,6 ]
Nagga, Katarina [7 ]
Kilander, Lena [8 ]
Religa, Dorota [2 ,3 ,4 ]
Wimo, Anders
Winblad, Bengt [2 ,3 ]
Rosengren, Lars [9 ]
Schott, Jonathan M. [10 ]
Blennow, Kaj [1 ]
Eriksdotter, Maria [2 ,3 ,4 ]
Zetterberg, Henrik [1 ,10 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neurochem,Clin Nerochem Lab, Molndal, Sweden
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden
[3] Karolinska Inst, KI Alzheimer Dis Res Ctr, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden
[5] London Sch Hyg & Trop Med, Ctr Stat Methodol, London WC1, England
[6] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA
[7] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden
[8] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden
[9] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neurol, Gothenburg, Sweden
[10] UCL Inst Neurol, London, England
基金
瑞典研究理事会;
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PROTEIN-LEVELS; WHITE-MATTER; FRONTOTEMPORAL DEMENTIA; DIAGNOSTIC-CRITERIA; BIOMARKERS; MARKER; MANAGEMENT;
D O I
10.1212/WNL.0000000000001015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We hypothesized that CSF neurofilament light (NFL) levels would be elevated in dementias with subcortical involvement, including vascular dementia (VaD), but less elevated in dementias primarily affecting gray matter structures, such as Alzheimer disease (AD), and that elevated CSF NFL would correlate with disease severity and shorter survival time irrespective of clinical diagnosis. Methods: We included 3,356 individuals with dementia who had CSF NFL analyzed in our laboratory between 2005 and 2012. Clinical diagnoses and Mini-Mental State Examination (MMSE) scores were obtained from the Swedish Dementia Registry, and in selected cases (n = 478), date of death from the Swedish Mortality Registry. Results: CSF NFL differed among clinical diagnoses, with the highest levels seen in frontotemporal dementia, VaD, and mixed AD and VaD. Early-onset AD (younger than 65 years) had the lowest levels. High CSF NFL correlated with low MMSE score and short survival time irrespective of diagnosis, and was also particularly evident in AD. Conclusions: CSF NFL differs among different neurodegenerative diseases and is especially high in dementias engaging subcortical brain regions, such as VaD and mixed AD and VaD, but also in frontotemporal dementia. The association of high CSF NFL levels with disease severity and short survival supports the notion that high CSF NFL levels indicate more aggressive disease processes.
引用
收藏
页码:1945 / 1953
页数:9
相关论文
共 50 条
  • [31] A neurofilament-light chains electrochemical immunosensor expected to reveal the early stage of neurodegenerative diseases
    Li, Wen-tao
    Dong, She-ying
    Chen, Hao
    An, Ya-qi
    Zhang, Jie
    Wang, Lan-ying
    Zhu, Jun-Jie
    CHEMICAL ENGINEERING JOURNAL, 2022, 446
  • [32] Stoichiometry of the CSF neurofilament heavy and light chains
    Petzold, A.
    Keir, G.
    Holmberg, B.
    Thompson, E.
    Rosengren, L.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S60 - S60
  • [33] CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
    Bhan, Alok
    Jacobsen, Cecilie
    Dalen, Ingvild
    Bergsland, Niels
    Zivadinov, Robert
    Alves, Guido
    Myhr, Kjell-Morten
    Farbu, Elisabeth
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (04)
  • [34] Neurofilament light A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Alves, Guido
    Bonanni, Laura
    NEUROLOGY, 2017, 88 (10) : 922 - 923
  • [35] Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study
    Gotze, Karl
    Vrillon, Agathe
    Dumurgier, Julien
    Indart, Sandrine
    Sanchez-Ortiz, Marta
    Slimi, Hela
    Raynaud-Simon, Agathe
    Cognat, Emmanuel
    Martinet, Matthieu
    Zetterberg, Henrik
    Blennow, Kaj
    Hourregue, Claire
    Bouaziz-Amar, Elodie
    Paquet, Claire
    Lilamand, Matthieu
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [36] Neurofilament-light chain (NfL) in the Vitreous Humor and its Correlation with Biomarkers Associated with Neurodegenerative Diseases
    Subramanian, Manju L.
    Vig, Viha
    Chung, Jaeyoon
    Fiorello, Marissa Gabrielle
    Zetterberg, Madeleine
    Zetterberg, Henrik
    Stein, Thor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [37] Serum/CSF-diagnostics in neurodegenerative diseases
    Kovacs, G. G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E500 - E500
  • [38] Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
    Skillback, Tobias
    Mattsson, Niklas
    Blennow, Kaj
    Zetterberg, Henrik
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 (5-6) : 397 - 403
  • [39] Is CSF neurofilament light chain measurement relevant for MS?
    Matsui, Makoto
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (06):
  • [40] Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis
    Wang, Shao-Yang
    Chen, Wei
    Xu, Wei
    Li, Jie-Qiong
    Hou, Xiao-He
    Ou, Ya-Nan
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (04) : 1353 - 1361